Iroquois Capital
North America, Tennessee, United States, Nashville
Description
Iroquois Capital, a private equity firm, specializes in seed- to late-stage, turnaround, growth capital, and PIPE investments.
Investor Profile
Iroquois Capital has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Post Ipo Equity, Private Equity rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, China.
- Strong thematic focus on Biotechnology, Medical, Health Care.
Stage Focus
- Series Unknown (50%)
- Post Ipo Equity (31%)
- Private Equity (6%)
- Series B (6%)
- Series C (6%)
Country Focus
- United States (81%)
- United Kingdom (13%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- China (6%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Biopharma
- Pharmaceutical
- Therapeutics
- Software
- Medical Device
- Information Technology
- Supply Chain Management
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
